+Search query
-Structure paper
Title | Structure-Based Discovery of Proline-Derived Arginase Inhibitors with Improved Oral Bioavailability for Immuno-Oncology. |
---|---|
Journal, issue, pages | Acs Med. Chem. Lett., Vol. 12, Page 1380-1388, Year 2021 |
Publish date | Oct 30, 2020 (structure data deposition date) |
Authors | Lu, M. / Zhang, H. / Li, D. / Childers, M. / Pu, Q. / Palte, R.L. / Gathiaka, S. / Lyons, T.W. / Palani, A. / Fan, P.W. ...Lu, M. / Zhang, H. / Li, D. / Childers, M. / Pu, Q. / Palte, R.L. / Gathiaka, S. / Lyons, T.W. / Palani, A. / Fan, P.W. / Spacciapoli, P. / Miller, J.R. / Cho, H. / Cheng, M. / Chakravarthy, K. / O'Neil, J. / Eangoor, P. / Beard, A. / Kim, H.Y. / Sauri, J. / Gunaydin, H. / Sloman, D.L. / Siliphaivanh, P. / Cumming, J. / Fischer, C. |
External links | Acs Med. Chem. Lett. / PubMed:34527178 |
Methods | X-ray diffraction |
Resolution | 1.801 - 2.27 Å |
Structure data | PDB-7klk: PDB-7kll: PDB-7klm: |
Chemicals | ChemComp-MN: ChemComp-XFP: ChemComp-EDO: ChemComp-HOH: ChemComp-XFG: ChemComp-0IZ: |
Source |
|
Keywords | HYDROLASE/INHIBITOR / Arginase / hydrolase / urea cycle / metabolism / HYDROLASE-INHIBITOR complex |